APO Research
Talk to an analyst

APO RESEARCH · REPORT

Parenteral Nutrition

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Parenteral Nutrition Market Analysis and Forecast 2026-2032

29 December 2025210 pages

Choose your research edition.

Industry ResearchParenteral Nutrition Industry Research Report 2026149 pages · $2,950 USDIndustry Growth & TrendsGlobal Parenteral Nutrition Industry Growth and Trends Forecast to 2032128 pages · $3,450 USDMarket StructureGlobal Parenteral Nutrition Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Parenteral Nutrition Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal Parenteral Nutrition Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Parenteral Nutrition market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Parenteral Nutrition is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Parenteral Nutrition is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Parenteral Nutrition is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Parenteral Nutrition is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Parenteral Nutrition include Lummy, Grand Life Sciences, Xi'an Libang Pharmaceutical, Weixinkang, King York, Kelun Pharma, Grifols, Haisco Pharmaceutical Group and China Meheco Kangli, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Parenteral Nutrition, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Parenteral Nutrition, also provides the sales of main regions and countries. Of the upcoming market potential for Parenteral Nutrition, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Parenteral Nutrition sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Parenteral Nutrition market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Parenteral Nutrition sales, projected growth trends, production technology, application and end-user industry.

Parenteral Nutrition Segment by Company

Lummy

Grand Life Sciences

Xi'an Libang Pharmaceutical

Weixinkang

King York

Kelun Pharma

Grifols

Haisco Pharmaceutical Group

China Meheco Kangli

Lionco Pharmaceutical

BBCA Pharmaceutical

Fresenius Kabi

Otsuka Pharmaceutical

Cisen

B. Braun

Baizheng Pharmaceutical

Baxter

Biokin Pharmaceutical

BBCA Pharmaceutical

JW Pharmaceutical

Aguettant

Parenteral Nutrition Segment by Type

Amino Acid

Alanyl-Glutamine

Heat and Fat Emulsion

Trace Elements

Vitamins

Parenteral Nutrition Segment by Application

One-Chamber

Two-Chamber

Three-Chamber

Parenteral Nutrition Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Parenteral Nutrition market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Parenteral Nutrition and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Parenteral Nutrition.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Parenteral Nutrition in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Parenteral Nutrition manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Parenteral Nutrition sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Parenteral Nutrition Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Amino Acid Major Manufacturers Table 3. Alanyl-Glutamine Major Manufacturers Table 4. Heat and Fat Emulsion Major Manufacturers Table 5. Trace Elements Major Manufacturers Table 6. Vitamins Major Manufacturers Table 7. Global Parenteral Nutrition Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. One-Chamber Major Manufacturers Table 9. Two-Chamber Major Manufacturers Table 10. Three-Chamber Major Manufacturers Table 11. Parenteral Nutrition Industry Trends Table 12. Parenteral Nutrition Industry Drivers Table 13. Parenteral Nutrition Industry Opportunities and Challenges Table 14. Parenteral Nutrition Industry Restraints Table 15. Global Parenteral Nutrition Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Parenteral Nutrition Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Parenteral Nutrition Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Parenteral Nutrition Revenue Market Share by Region (2021-2026) Table 19. Global Parenteral Nutrition Revenue Market Share by Region (2027-2032) Table 20. Global Parenteral Nutrition Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M Units) Table 21. Global Parenteral Nutrition Sales by Region (2021-2026) & (M Units) Table 22. Global Parenteral Nutrition Sales by Region (2027-2032) & (M Units) Table 23. Global Parenteral Nutrition Sales Market Share by Region (2021-2026) Table 24. Global Parenteral Nutrition Sales Market Share by Region (2027-2032) Table 25. Global Parenteral Nutrition Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Parenteral Nutrition Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Parenteral Nutrition Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Parenteral Nutrition Sales Market Share by Manufacturers (2021-2026) Table 29. Global Parenteral Nutrition Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global Parenteral Nutrition Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Parenteral Nutrition Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Parenteral Nutrition Manufacturers, Product Type & Application Table 33. Global Parenteral Nutrition Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Parenteral Nutrition by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Parenteral Nutrition Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Parenteral Nutrition Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Parenteral Nutrition Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Parenteral Nutrition Revenue Market Share by Type (2021-2026) Table 40. Global Parenteral Nutrition Revenue Market Share by Type (2027-2032) Table 41. Global Parenteral Nutrition Sales by Type 2021 VS 2025 VS 2032 (M Units) Table 42. Global Parenteral Nutrition Sales by Type (2021-2026) & (M Units) Table 43. Global Parenteral Nutrition Sales by Type (2027-2032) & (M Units) Table 44. Global Parenteral Nutrition Sales Market Share by Type (2021-2026) Table 45. Global Parenteral Nutrition Sales Market Share by Type (2027-2032) Table 46. Global Parenteral Nutrition Price by Type (2021-2026) & (US$/Unit) Table 47. Global Parenteral Nutrition Price by Type (2027-2032) & (US$/Unit) Table 48. Global Parenteral Nutrition Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Parenteral Nutrition Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Parenteral Nutrition Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Parenteral Nutrition Revenue Market Share by Application (2021-2026) Table 52. Global Parenteral Nutrition Revenue Market Share by Application (2027-2032) Table 53. Global Parenteral Nutrition Sales by Application 2021 VS 2025 VS 2032 (M Units) Table 54. Global Parenteral Nutrition Sales by Application (2021-2026) & (M Units) Table 55. Global Parenteral Nutrition Sales by Application (2027-2032) & (M Units) Table 56. Global Parenteral Nutrition Sales Market Share by Application (2021-2026) Table 57. Global Parenteral Nutrition Sales Market Share by Application (2027-2032) Table 58. Global Parenteral Nutrition Price by Application (2021-2026) & (US$/Unit) Table 59. Global Parenteral Nutrition Price by Application (2027-2032) & (US$/Unit) Table 60. Lummy Company Information Table 61. Lummy Business Overview Table 62. Lummy Parenteral Nutrition Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. Lummy Parenteral Nutrition Product Portfolio Table 64. Lummy Recent Development Table 65. Grand Life Sciences Company Information Table 66. Grand Life Sciences Business Overview Table 67. Grand Life Sciences Parenteral Nutrition Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Grand Life Sciences Parenteral Nutrition Product Portfolio Table 69. Grand Life Sciences Recent Development Table 70. Xi'an Libang Pharmaceutical Company Information Table 71. Xi'an Libang Pharmaceutical Business Overview Table 72. Xi'an Libang Pharmaceutical Parenteral Nutrition Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Xi'an Libang Pharmaceutical Parenteral Nutrition Product Portfolio Table 74. Xi'an Libang Pharmaceutical Recent Development Table 75. Weixinkang Company Information Table 76. Weixinkang Business Overview Table 77. Weixinkang Parenteral Nutrition Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Weixinkang Parenteral Nutrition Product Portfolio Table 79. Weixinkang Recent Development Table 80. King York Company Information Table 81. King York Business Overview Table 82. King York Parenteral Nutrition Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. King York Parenteral Nutrition Product Portfolio Table 84. King York Recent Development Table 85. Kelun Pharma Company Information Table 86. Kelun Pharma Business Overview Table 87. Kelun Pharma Parenteral Nutrition Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Kelun Pharma Parenteral Nutrition Product Portfolio Table 89. Kelun Pharma Recent Development Table 90. Grifols Company Information Table 91. Grifols Business Overview Table 92. Grifols Parenteral Nutrition Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Grifols Parenteral Nutrition Product Portfolio Table 94. Grifols Recent Development Table 95. Haisco Pharmaceutical Group Company Information Table 96. Haisco Pharmaceutical Group Business Overview Table 97. Haisco Pharmaceutical Group Parenteral Nutrition Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Haisco Pharmaceutical Group Parenteral Nutrition Product Portfolio Table 99. Haisco Pharmaceutical Group Recent Development Table 100. China Meheco Kangli Company Information Table 101. China Meheco Kangli Business Overview Table 102. China Meheco Kangli Parenteral Nutrition Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. China Meheco Kangli Parenteral Nutrition Product Portfolio Table 104. China Meheco Kangli Recent Development Table 105. Lionco Pharmaceutical Company Information Table 106. Lionco Pharmaceutical Business Overview Table 107. Lionco Pharmaceutical Parenteral Nutrition Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Lionco Pharmaceutical Parenteral Nutrition Product Portfolio Table 109. Lionco Pharmaceutical Recent Development Table 110. BBCA Pharmaceutical Company Information Table 111. BBCA Pharmaceutical Business Overview Table 112. BBCA Pharmaceutical Parenteral Nutrition Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. BBCA Pharmaceutical Parenteral Nutrition Product Portfolio Table 114. BBCA Pharmaceutical Recent Development Table 115. Fresenius Kabi Company Information Table 116. Fresenius Kabi Business Overview Table 117. Fresenius Kabi Parenteral Nutrition Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Fresenius Kabi Parenteral Nutrition Product Portfolio Table 119. Fresenius Kabi Recent Development Table 120. Otsuka Pharmaceutical Company Information Table 121. Otsuka Pharmaceutical Business Overview Table 122. Otsuka Pharmaceutical Parenteral Nutrition Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Otsuka Pharmaceutical Parenteral Nutrition Product Portfolio Table 124. Otsuka Pharmaceutical Recent Development Table 125. Cisen Company Information Table 126. Cisen Business Overview Table 127. Cisen Parenteral Nutrition Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Cisen Parenteral Nutrition Product Portfolio Table 129. Cisen Recent Development Table 130. B. Braun Company Information Table 131. B. Braun Business Overview Table 132. B. Braun Parenteral Nutrition Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. B. Braun Parenteral Nutrition Product Portfolio Table 134. B. Braun Recent Development Table 135. Baizheng Pharmaceutical Company Information Table 136. Baizheng Pharmaceutical Business Overview Table 137. Baizheng Pharmaceutical Parenteral Nutrition Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. Baizheng Pharmaceutical Parenteral Nutrition Product Portfolio Table 139. Baizheng Pharmaceutical Recent Development Table 140. Baxter Company Information Table 141. Baxter Business Overview Table 142. Baxter Parenteral Nutrition Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 143. Baxter Parenteral Nutrition Product Portfolio Table 144. Baxter Recent Development Table 145. Biokin Pharmaceutical Company Information Table 146. Biokin Pharmaceutical Business Overview Table 147. Biokin Pharmaceutical Parenteral Nutrition Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 148. Biokin Pharmaceutical Parenteral Nutrition Product Portfolio Table 149. Biokin Pharmaceutical Recent Development Table 150. BBCA Pharmaceutical Company Information Table 151. BBCA Pharmaceutical Business Overview Table 152. BBCA Pharmaceutical Parenteral Nutrition Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 153. BBCA Pharmaceutical Parenteral Nutrition Product Portfolio Table 154. BBCA Pharmaceutical Recent Development Table 155. JW Pharmaceutical Company Information Table 156. JW Pharmaceutical Business Overview Table 157. JW Pharmaceutical Parenteral Nutrition Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 158. JW Pharmaceutical Parenteral Nutrition Product Portfolio Table 159. JW Pharmaceutical Recent Development Table 160. Aguettant Company Information Table 161. Aguettant Business Overview Table 162. Aguettant Parenteral Nutrition Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 163. Aguettant Parenteral Nutrition Product Portfolio Table 164. Aguettant Recent Development Table 165. North America Parenteral Nutrition Revenue by Type (2021-2026) & (US$ Million) Table 166. North America Parenteral Nutrition Revenue by Type (2027-2032) & (US$ Million) Table 167. North America Parenteral Nutrition Sales by Type (2021-2026) & (M Units) Table 168. North America Parenteral Nutrition Sales by Type (2027-2032) & (M Units) Table 169. North America Parenteral Nutrition Sales Price by Type (2021-2026) & (US$/Unit) Table 170. North America Parenteral Nutrition Sales Price by Type (2027-2032) & (US$/Unit) Table 171. North America Parenteral Nutrition Revenue by Application (2021-2026) & (US$ Million) Table 172. North America Parenteral Nutrition Revenue by Application (2027-2032) & (US$ Million) Table 173. North America Parenteral Nutrition Sales by Application (2021-2026) & (M Units) Table 174. North America Parenteral Nutrition Sales by Application (2027-2032) & (M Units) Table 175. North America Parenteral Nutrition Sales Price by Application (2021-2026) & (US$/Unit) Table 176. North America Parenteral Nutrition Sales Price by Application (2027-2032) & (US$/Unit) Table 177. North America Parenteral Nutrition Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 178. North America Parenteral Nutrition Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 179. North America Parenteral Nutrition Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 180. North America Parenteral Nutrition Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 181. North America Parenteral Nutrition Sales by Country (2021-2026) & (M Units) Table 182. North America Parenteral Nutrition Sales by Country (2027-2032) & (M Units) Table 183. North America Parenteral Nutrition Sales Price by Country (2021-2026) & (US$/Unit) Table 184. North America Parenteral Nutrition Sales Price by Country (2027-2032) & (US$/Unit) Table 185. United States Parenteral Nutrition Revenue (2021-2032) & (US$ Million) Table 186. Canada Parenteral Nutrition Revenue (2021-2032) & (US$ Million) Table 187. Europe Parenteral Nutrition Revenue by Type (2021-2026) & (US$ Million) Table 188. Europe Parenteral Nutrition Revenue by Type (2027-2032) & (US$ Million) Table 189. Europe Parenteral Nutrition Sales by Type (2021-2026) & (M Units) Table 190. Europe Parenteral Nutrition Sales by Type (2027-2032) & (M Units) Table 191. Europe Parenteral Nutrition Sales Price by Type (2021-2026) & (US$/Unit) Table 192. Europe Parenteral Nutrition Sales Price by Type (2027-2032) & (US$/Unit) Table 193. Europe Parenteral Nutrition Revenue by Application (2021-2026) & (US$ Million) Table 194. Europe Parenteral Nutrition Revenue by Application (2027-2032) & (US$ Million) Table 195. Europe Parenteral Nutrition Sales by Application (2021-2026) & (M Units) Table 196. Europe Parenteral Nutrition Sales by Application (2027-2032) & (M Units) Table 197. Europe Parenteral Nutrition Sales Price by Application (2021-2026) & (US$/Unit) Table 198. Europe Parenteral Nutrition Sales Price by Application (2027-2032) & (US$/Unit) Table 199. Europe Parenteral Nutrition Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 200. Europe Parenteral Nutrition Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 201. Europe Parenteral Nutrition Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 202. Europe Parenteral Nutrition Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 203. Europe Parenteral Nutrition Sales by Country (2021-2026) & (M Units) Table 204. Europe Parenteral Nutrition Sales by Country (2027-2032) & (M Units) Table 205. Europe Parenteral Nutrition Sales Price by Country (2021-2026) & (US$/Unit) Table 206. Europe Parenteral Nutrition Sales Price by Country (2027-2032) & (US$/Unit) Table 207. Germany Parenteral Nutrition Revenue (2021-2032) & (US$ Million) Table 208. France Parenteral Nutrition Revenue (2021-2032) & (US$ Million) Table 209. U.K. Parenteral Nutrition Revenue (2021-2032) & (US$ Million) Table 210. Italy Parenteral Nutrition Revenue (2021-2032) & (US$ Million) Table 211. Netherlands Parenteral Nutrition Revenue (2021-2032) & (US$ Million) Table 212. Nordic Countries Parenteral Nutrition Revenue (2021-2032) & (US$ Million) Table 213. China Parenteral Nutrition Revenue by Type (2021-2026) & (US$ Million) Table 214. China Parenteral Nutrition Revenue by Type (2027-2032) & (US$ Million) Table 215. China Parenteral Nutrition Sales by Type (2021-2026) & (M Units) Table 216. China Parenteral Nutrition Sales by Type (2027-2032) & (M Units) Table 217. China Parenteral Nutrition Sales Price by Type (2021-2026) & (US$/Unit) Table 218. China Parenteral Nutrition Sales Price by Type (2027-2032) & (US$/Unit) Table 219. China Parenteral Nutrition Revenue by Application (2021-2026) & (US$ Million) Table 220. China Parenteral Nutrition Revenue by Application (2027-2032) & (US$ Million) Table 221. China Parenteral Nutrition Sales by Application (2021-2026) & (M Units) Table 222. China Parenteral Nutrition Sales by Application (2027-2032) & (M Units) Table 223. China Parenteral Nutrition Sales Price by Application (2021-2026) & (US$/Unit) Table 224. China Parenteral Nutrition Sales Price by Application (2027-2032) & (US$/Unit) Table 225. Asia Parenteral Nutrition Revenue by Type (2021-2026) & (US$ Million) Table 226. Asia Parenteral Nutrition Revenue by Type (2027-2032) & (US$ Million) Table 227. Asia Parenteral Nutrition Sales by Type (2021-2026) & (M Units) Table 228. Asia Parenteral Nutrition Sales by Type (2027-2032) & (M Units) Table 229. Asia Parenteral Nutrition Sales Price by Type (2021-2026) & (US$/Unit) Table 230. Asia Parenteral Nutrition Sales Price by Type (2027-2032) & (US$/Unit) Table 231. Asia Parenteral Nutrition Revenue by Application (2021-2026) & (US$ Million) Table 232. Asia Parenteral Nutrition Revenue by Application (2027-2032) & (US$ Million) Table 233. Asia Parenteral Nutrition Sales by Application (2021-2026) & (M Units) Table 234. Asia Parenteral Nutrition Sales by Application (2027-2032) & (M Units) Table 235. Asia Parenteral Nutrition Sales Price by Application (2021-2026) & (US$/Unit) Table 236. Asia Parenteral Nutrition Sales Price by Application (2027-2032) & (US$/Unit) Table 237. Asia Parenteral Nutrition Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 238. Asia Parenteral Nutrition Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 239. Asia Parenteral Nutrition Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 240. Asia Parenteral Nutrition Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 241. Asia Parenteral Nutrition Sales by Country (2021-2026) & (M Units) Table 242. Asia Parenteral Nutrition Sales by Country (2027-2032) & (M Units) Table 243. Asia Parenteral Nutrition Sales Price by Country (2021-2026) & (US$/Unit) Table 244. Asia Parenteral Nutrition Sales Price by Country (2027-2032) & (US$/Unit) Table 245. Japan Parenteral Nutrition Revenue (2021-2032) & (US$ Million) Table 246. South Korea Parenteral Nutrition Revenue (2021-2032) & (US$ Million) Table 247. India Parenteral Nutrition Revenue (2021-2032) & (US$ Million) Table 248. Australia Parenteral Nutrition Revenue (2021-2032) & (US$ Million) Table 249. China Taiwan Parenteral Nutrition Revenue (2021-2032) & (US$ Million) Table 250. Southeast Asia Parenteral Nutrition Revenue (2021-2032) & (US$ Million) Table 251. SAMEA Parenteral Nutrition Revenue by Type (2021-2026) & (US$ Million) Table 252. SAMEA Parenteral Nutrition Revenue by Type (2027-2032) & (US$ Million) Table 253. SAMEA Parenteral Nutrition Sales by Type (2021-2026) & (M Units) Table 254. SAMEA Parenteral Nutrition Sales by Type (2027-2032) & (M Units) Table 255. SAMEA Parenteral Nutrition Sales Price by Type (2021-2026) & (US$/Unit) Table 256. SAMEA Parenteral Nutrition Sales Price by Type (2027-2032) & (US$/Unit) Table 257. SAMEA Parenteral Nutrition Revenue by Application (2021-2026) & (US$ Million) Table 258. SAMEA Parenteral Nutrition Revenue by Application (2027-2032) & (US$ Million) Table 259. SAMEA Parenteral Nutrition Sales by Application (2021-2026) & (M Units) Table 260. SAMEA Parenteral Nutrition Sales by Application (2027-2032) & (M Units) Table 261. SAMEA Parenteral Nutrition Sales Price by Application (2021-2026) & (US$/Unit) Table 262. SAMEA Parenteral Nutrition Sales Price by Application (2027-2032) & (US$/Unit) Table 263. SAMEA Parenteral Nutrition Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 264. SAMEA Parenteral Nutrition Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 265. SAMEA Parenteral Nutrition Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 266. SAMEA Parenteral Nutrition Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 267. SAMEA Parenteral Nutrition Sales by Country (2021-2026) & (M Units) Table 268. SAMEA Parenteral Nutrition Sales by Country (2027-2032) & (M Units) Table 269. SAMEA Parenteral Nutrition Sales Price by Country (2021-2026) & (US$/Unit) Table 270. SAMEA Parenteral Nutrition Sales Price by Country (2027-2032) & (US$/Unit) Table 271. Brazil Parenteral Nutrition Revenue (2021-2032) & (US$ Million) Table 272. Argentina Parenteral Nutrition Revenue (2021-2032) & (US$ Million) Table 273. Chile Parenteral Nutrition Revenue (2021-2032) & (US$ Million) Table 274. Colombia Parenteral Nutrition Revenue (2021-2032) & (US$ Million) Table 275. Peru Parenteral Nutrition Revenue (2021-2032) & (US$ Million) Table 276. Saudi Arabia Parenteral Nutrition Revenue (2021-2032) & (US$ Million) Table 277. Israel Parenteral Nutrition Revenue (2021-2032) & (US$ Million) Table 278. UAE Parenteral Nutrition Revenue (2021-2032) & (US$ Million) Table 279. Turkey Parenteral Nutrition Revenue (2021-2032) & (US$ Million) Table 280. Iran Parenteral Nutrition Revenue (2021-2032) & (US$ Million) Table 281. Egypt Parenteral Nutrition Revenue (2021-2032) & (US$ Million) Table 282. Key Raw Materials Table 283. Raw Materials Key Suppliers Table 284. Parenteral Nutrition Distributors List Table 285. Parenteral Nutrition Customers List Table 286. Research Programs/Design for This Report Table 287. Authors List of This Report Table 288. Secondary Sources Table 289. Primary Sources List of Figures Figure 1. Parenteral Nutrition Image Figure 2. Global Parenteral Nutrition Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Parenteral Nutrition Market Size Share 2021 VS 2025 VS 2032 Figure 4. Amino Acid Image Figure 5. Alanyl-Glutamine Image Figure 6. Heat and Fat Emulsion Image Figure 7. Trace Elements Image Figure 8. Vitamins Image Figure 9. Global Parenteral Nutrition Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Parenteral Nutrition Market Size Share 2021 VS 2025 VS 2032 Figure 11. One-Chamber Image Figure 12. Two-Chamber Image Figure 13. Three-Chamber Image Figure 14. Global Parenteral Nutrition Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Parenteral Nutrition Revenue (2021-2032) & (US$ Million) Figure 16. Global Parenteral Nutrition Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Parenteral Nutrition Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Parenteral Nutrition Revenue Market Share by Region (2021-2032) Figure 19. Global Parenteral Nutrition Sales (2021-2032) & (M Units) Figure 20. Global Parenteral Nutrition Sales by Region: 2021 VS 2025 VS 2032 (M Units) Figure 21. Global Parenteral Nutrition Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Parenteral Nutrition Sales YoY (2021-2032) & (M Units) Figure 23. Europe Parenteral Nutrition Sales YoY (2021-2032) & (M Units) Figure 24. China Parenteral Nutrition Sales YoY (2021-2032) & (M Units) Figure 25. Asia (Excluding China) Parenteral Nutrition Sales YoY (2021-2032) & (M Units) Figure 26. South America, Middle East and Africa Parenteral Nutrition Sales YoY (2021-2032) & (M Units) Figure 27. Global Parenteral Nutrition Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Parenteral Nutrition Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Parenteral Nutrition Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Parenteral Nutrition Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Parenteral Nutrition Revenue Market Share by Type (2021-2032) Figure 33. Global Parenteral Nutrition Sales by Type (2021 VS 2025 VS 2032) & (M Units) Figure 34. Global Parenteral Nutrition Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Parenteral Nutrition Sales Market Share by Type (2021-2032) Figure 36. Global Parenteral Nutrition Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Parenteral Nutrition Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Parenteral Nutrition Revenue Market Share by Application (2021-2032) Figure 39. Global Parenteral Nutrition Sales by Application (2021 VS 2025 VS 2032) & (M Units) Figure 40. Global Parenteral Nutrition Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Parenteral Nutrition Sales Market Share by Application (2021-2032) Figure 42. North America Parenteral Nutrition Revenue Share by Type (2021-2032) Figure 43. North America Parenteral Nutrition Sales Share by Type (2021-2032) Figure 44. North America Parenteral Nutrition Revenue Share by Application (2021-2032) Figure 45. North America Parenteral Nutrition Sales Share by Application (2021-2032) Figure 46. North America Parenteral Nutrition Revenue Share by Country (2021-2032) Figure 47. North America Parenteral Nutrition Sales Share by Country (2021-2032) Figure 48. Europe Parenteral Nutrition Revenue Share by Type (2021-2032) Figure 49. Europe Parenteral Nutrition Sales Share by Type (2021-2032) Figure 50. Europe Parenteral Nutrition Revenue Share by Application (2021-2032) Figure 51. Europe Parenteral Nutrition Sales Share by Application (2021-2032) Figure 52. Europe Parenteral Nutrition Revenue Share by Country (2021-2032) Figure 53. Europe Parenteral Nutrition Sales Share by Country (2021-2032) Figure 54. China Parenteral Nutrition Revenue Share by Type (2021-2032) Figure 55. China Parenteral Nutrition Sales Share by Type (2021-2032) Figure 56. China Parenteral Nutrition Revenue Share by Application (2021-2032) Figure 57. China Parenteral Nutrition Sales Share by Application (2021-2032) Figure 58. Asia Parenteral Nutrition Revenue Share by Type (2021-2032) Figure 59. Asia Parenteral Nutrition Sales Share by Type (2021-2032) Figure 60. Asia Parenteral Nutrition Revenue Share by Application (2021-2032) Figure 61. Asia Parenteral Nutrition Sales Share by Application (2021-2032) Figure 62. Asia Parenteral Nutrition Revenue Share by Country (2021-2032) Figure 63. Asia Parenteral Nutrition Sales Share by Country (2021-2032) Figure 64. SAMEA Parenteral Nutrition Revenue Share by Type (2021-2032) Figure 65. SAMEA Parenteral Nutrition Sales Share by Type (2021-2032) Figure 66. SAMEA Parenteral Nutrition Revenue Share by Application (2021-2032) Figure 67. SAMEA Parenteral Nutrition Sales Share by Application (2021-2032) Figure 68. SAMEA Parenteral Nutrition Revenue Share by Country (2021-2032) Figure 69. SAMEA Parenteral Nutrition Sales Share by Country (2021-2032) Figure 70. Parenteral Nutrition Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Parenteral Nutrition Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Amino Acid
  • Alanyl-Glutamine
  • Heat and Fat Emulsion
  • Trace Elements
  • Vitamins
Applications
  • One-Chamber
  • Two-Chamber
  • Three-Chamber
Companies covered
  • Lummy
  • Grand Life Sciences
  • Xi'an Libang Pharmaceutical
  • Weixinkang
  • King York
  • Kelun Pharma
  • Grifols
  • Haisco Pharmaceutical Group
  • China Meheco Kangli
  • Lionco Pharmaceutical
  • BBCA Pharmaceutical
  • Fresenius Kabi
  • Otsuka Pharmaceutical
  • Cisen
  • B. Braun
  • Baizheng Pharmaceutical
  • Baxter
  • Biokin Pharmaceutical
  • BBCA Pharmaceutical
  • JW Pharmaceutical
  • Aguettant

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Parenteral Nutrition Market by Type
  3. 1.2.1 Global Parenteral Nutrition Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Amino Acid
  5. 1.2.3 Alanyl-Glutamine
  6. 1.2.4 Heat and Fat Emulsion
  7. 1.2.5 Trace Elements
  8. 1.2.6 Vitamins
  9. 1.3 Parenteral Nutrition Market by Application
  10. 1.3.1 Global Parenteral Nutrition Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 One-Chamber
  12. 1.3.3 Two-Chamber
  13. 1.3.4 Three-Chamber
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Parenteral Nutrition Market Dynamics
  1. 2.1 Parenteral Nutrition Industry Trends
  2. 2.2 Parenteral Nutrition Industry Drivers
  3. 2.3 Parenteral Nutrition Industry Opportunities and Challenges
  4. 2.4 Parenteral Nutrition Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Parenteral Nutrition Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Parenteral Nutrition Revenue by Region
  3. 3.2.1 Global Parenteral Nutrition Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Parenteral Nutrition Revenue by Region (2021-2026)
  5. 3.2.3 Global Parenteral Nutrition Revenue by Region (2027-2032)
  6. 3.2.4 Global Parenteral Nutrition Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Parenteral Nutrition Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Parenteral Nutrition Sales by Region
  9. 3.4.1 Global Parenteral Nutrition Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Parenteral Nutrition Sales by Region (2021-2026)
  11. 3.4.3 Global Parenteral Nutrition Sales by Region (2027-2032)
  12. 3.4.4 Global Parenteral Nutrition Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Parenteral Nutrition Revenue by Manufacturers
  2. 4.1.1 Global Parenteral Nutrition Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Parenteral Nutrition Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Parenteral Nutrition Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Parenteral Nutrition Sales by Manufacturers
  6. 4.2.1 Global Parenteral Nutrition Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Parenteral Nutrition Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Parenteral Nutrition Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Parenteral Nutrition Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Parenteral Nutrition Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Parenteral Nutrition Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Parenteral Nutrition Manufacturers, Product Type & Application
  13. 4.7 Global Parenteral Nutrition Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Parenteral Nutrition Market CR5 and HHI
  16. 4.8.2 2025 Parenteral Nutrition Tier 1, Tier 2, and Tier 3
5 Parenteral Nutrition Market by Type
  1. 5.1 Global Parenteral Nutrition Revenue by Type
  2. 5.1.1 Global Parenteral Nutrition Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Parenteral Nutrition Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Parenteral Nutrition Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Parenteral Nutrition Sales by Type
  6. 5.2.1 Global Parenteral Nutrition Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Parenteral Nutrition Sales by Type (2021-2032) & (M Units)
  8. 5.2.3 Global Parenteral Nutrition Sales Market Share by Type (2021-2032)
  9. 5.3 Global Parenteral Nutrition Price by Type
6 Parenteral Nutrition Market by Application
  1. 6.1 Global Parenteral Nutrition Revenue by Application
  2. 6.1.1 Global Parenteral Nutrition Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Parenteral Nutrition Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Parenteral Nutrition Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Parenteral Nutrition Sales by Application
  6. 6.2.1 Global Parenteral Nutrition Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Parenteral Nutrition Sales by Application (2021-2032) & (M Units)
  8. 6.2.3 Global Parenteral Nutrition Sales Market Share by Application (2021-2032)
  9. 6.3 Global Parenteral Nutrition Price by Application
7 Company Profiles
  1. 7.1 Lummy
  2. 7.1.1 Lummy Company Information
  3. 7.1.2 Lummy Business Overview
  4. 7.1.3 Lummy Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Lummy Parenteral Nutrition Product Portfolio
  6. 7.1.5 Lummy Recent Developments
  7. 7.2 Grand Life Sciences
  8. 7.2.1 Grand Life Sciences Company Information
  9. 7.2.2 Grand Life Sciences Business Overview
  10. 7.2.3 Grand Life Sciences Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Grand Life Sciences Parenteral Nutrition Product Portfolio
  12. 7.2.5 Grand Life Sciences Recent Developments
  13. 7.3 Xi'an Libang Pharmaceutical
  14. 7.3.1 Xi'an Libang Pharmaceutical Company Information
  15. 7.3.2 Xi'an Libang Pharmaceutical Business Overview
  16. 7.3.3 Xi'an Libang Pharmaceutical Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Xi'an Libang Pharmaceutical Parenteral Nutrition Product Portfolio
  18. 7.3.5 Xi'an Libang Pharmaceutical Recent Developments
  19. 7.4 Weixinkang
  20. 7.4.1 Weixinkang Company Information
  21. 7.4.2 Weixinkang Business Overview
  22. 7.4.3 Weixinkang Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Weixinkang Parenteral Nutrition Product Portfolio
  24. 7.4.5 Weixinkang Recent Developments
  25. 7.5 King York
  26. 7.5.1 King York Company Information
  27. 7.5.2 King York Business Overview
  28. 7.5.3 King York Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 King York Parenteral Nutrition Product Portfolio
  30. 7.5.5 King York Recent Developments
  31. 7.6 Kelun Pharma
  32. 7.6.1 Kelun Pharma Company Information
  33. 7.6.2 Kelun Pharma Business Overview
  34. 7.6.3 Kelun Pharma Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Kelun Pharma Parenteral Nutrition Product Portfolio
  36. 7.6.5 Kelun Pharma Recent Developments
  37. 7.7 Grifols
  38. 7.7.1 Grifols Company Information
  39. 7.7.2 Grifols Business Overview
  40. 7.7.3 Grifols Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Grifols Parenteral Nutrition Product Portfolio
  42. 7.7.5 Grifols Recent Developments
  43. 7.8 Haisco Pharmaceutical Group
  44. 7.8.1 Haisco Pharmaceutical Group Company Information
  45. 7.8.2 Haisco Pharmaceutical Group Business Overview
  46. 7.8.3 Haisco Pharmaceutical Group Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Haisco Pharmaceutical Group Parenteral Nutrition Product Portfolio
  48. 7.8.5 Haisco Pharmaceutical Group Recent Developments
  49. 7.9 China Meheco Kangli
  50. 7.9.1 China Meheco Kangli Company Information
  51. 7.9.2 China Meheco Kangli Business Overview
  52. 7.9.3 China Meheco Kangli Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 China Meheco Kangli Parenteral Nutrition Product Portfolio
  54. 7.9.5 China Meheco Kangli Recent Developments
  55. 7.10 Lionco Pharmaceutical
  56. 7.10.1 Lionco Pharmaceutical Company Information
  57. 7.10.2 Lionco Pharmaceutical Business Overview
  58. 7.10.3 Lionco Pharmaceutical Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Lionco Pharmaceutical Parenteral Nutrition Product Portfolio
  60. 7.10.5 Lionco Pharmaceutical Recent Developments
  61. 7.11 BBCA Pharmaceutical
  62. 7.11.1 BBCA Pharmaceutical Company Information
  63. 7.11.2 BBCA Pharmaceutical Business Overview
  64. 7.11.3 BBCA Pharmaceutical Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 BBCA Pharmaceutical Parenteral Nutrition Product Portfolio
  66. 7.11.5 BBCA Pharmaceutical Recent Developments
  67. 7.12 Fresenius Kabi
  68. 7.12.1 Fresenius Kabi Company Information
  69. 7.12.2 Fresenius Kabi Business Overview
  70. 7.12.3 Fresenius Kabi Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Fresenius Kabi Parenteral Nutrition Product Portfolio
  72. 7.12.5 Fresenius Kabi Recent Developments
  73. 7.13 Otsuka Pharmaceutical
  74. 7.13.1 Otsuka Pharmaceutical Company Information
  75. 7.13.2 Otsuka Pharmaceutical Business Overview
  76. 7.13.3 Otsuka Pharmaceutical Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Otsuka Pharmaceutical Parenteral Nutrition Product Portfolio
  78. 7.13.5 Otsuka Pharmaceutical Recent Developments
  79. 7.14 Cisen
  80. 7.14.1 Cisen Company Information
  81. 7.14.2 Cisen Business Overview
  82. 7.14.3 Cisen Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Cisen Parenteral Nutrition Product Portfolio
  84. 7.14.5 Cisen Recent Developments
  85. 7.15 B. Braun
  86. 7.15.1 B. Braun Company Information
  87. 7.15.2 B. Braun Business Overview
  88. 7.15.3 B. Braun Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 B. Braun Parenteral Nutrition Product Portfolio
  90. 7.15.5 B. Braun Recent Developments
  91. 7.16 Baizheng Pharmaceutical
  92. 7.16.1 Baizheng Pharmaceutical Company Information
  93. 7.16.2 Baizheng Pharmaceutical Business Overview
  94. 7.16.3 Baizheng Pharmaceutical Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Baizheng Pharmaceutical Parenteral Nutrition Product Portfolio
  96. 7.16.5 Baizheng Pharmaceutical Recent Developments
  97. 7.17 Baxter
  98. 7.17.1 Baxter Company Information
  99. 7.17.2 Baxter Business Overview
  100. 7.17.3 Baxter Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Baxter Parenteral Nutrition Product Portfolio
  102. 7.17.5 Baxter Recent Developments
  103. 7.18 Biokin Pharmaceutical
  104. 7.18.1 Biokin Pharmaceutical Company Information
  105. 7.18.2 Biokin Pharmaceutical Business Overview
  106. 7.18.3 Biokin Pharmaceutical Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Biokin Pharmaceutical Parenteral Nutrition Product Portfolio
  108. 7.18.5 Biokin Pharmaceutical Recent Developments
  109. 7.19 BBCA Pharmaceutical
  110. 7.19.1 BBCA Pharmaceutical Company Information
  111. 7.19.2 BBCA Pharmaceutical Business Overview
  112. 7.19.3 BBCA Pharmaceutical Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 BBCA Pharmaceutical Parenteral Nutrition Product Portfolio
  114. 7.19.5 BBCA Pharmaceutical Recent Developments
  115. 7.20 JW Pharmaceutical
  116. 7.20.1 JW Pharmaceutical Company Information
  117. 7.20.2 JW Pharmaceutical Business Overview
  118. 7.20.3 JW Pharmaceutical Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 JW Pharmaceutical Parenteral Nutrition Product Portfolio
  120. 7.20.5 JW Pharmaceutical Recent Developments
  121. 7.21 Aguettant
  122. 7.21.1 Aguettant Company Information
  123. 7.21.2 Aguettant Business Overview
  124. 7.21.3 Aguettant Parenteral Nutrition Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Aguettant Parenteral Nutrition Product Portfolio
  126. 7.21.5 Aguettant Recent Developments
8 North America
  1. 8.1 North America Parenteral Nutrition Market Size by Type
  2. 8.1.1 North America Parenteral Nutrition Revenue by Type (2021-2032)
  3. 8.1.2 North America Parenteral Nutrition Sales by Type (2021-2032)
  4. 8.1.3 North America Parenteral Nutrition Price by Type (2021-2032)
  5. 8.2 North America Parenteral Nutrition Market Size by Application
  6. 8.2.1 North America Parenteral Nutrition Revenue by Application (2021-2032)
  7. 8.2.2 North America Parenteral Nutrition Sales by Application (2021-2032)
  8. 8.2.3 North America Parenteral Nutrition Price by Application (2021-2032)
  9. 8.3 North America Parenteral Nutrition Market Size by Country
  10. 8.3.1 North America Parenteral Nutrition Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Parenteral Nutrition Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Parenteral Nutrition Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Parenteral Nutrition Market Size by Type
  2. 9.1.1 Europe Parenteral Nutrition Revenue by Type (2021-2032)
  3. 9.1.2 Europe Parenteral Nutrition Sales by Type (2021-2032)
  4. 9.1.3 Europe Parenteral Nutrition Price by Type (2021-2032)
  5. 9.2 Europe Parenteral Nutrition Market Size by Application
  6. 9.2.1 Europe Parenteral Nutrition Revenue by Application (2021-2032)
  7. 9.2.2 Europe Parenteral Nutrition Sales by Application (2021-2032)
  8. 9.2.3 Europe Parenteral Nutrition Price by Application (2021-2032)
  9. 9.3 Europe Parenteral Nutrition Market Size by Country
  10. 9.3.1 Europe Parenteral Nutrition Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Parenteral Nutrition Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Parenteral Nutrition Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Parenteral Nutrition Market Size by Type
  2. 10.1.1 China Parenteral Nutrition Revenue by Type (2021-2032)
  3. 10.1.2 China Parenteral Nutrition Sales by Type (2021-2032)
  4. 10.1.3 China Parenteral Nutrition Price by Type (2021-2032)
  5. 10.2 China Parenteral Nutrition Market Size by Application
  6. 10.2.1 China Parenteral Nutrition Revenue by Application (2021-2032)
  7. 10.2.2 China Parenteral Nutrition Sales by Application (2021-2032)
  8. 10.2.3 China Parenteral Nutrition Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Parenteral Nutrition Market Size by Type
  2. 11.1.1 Asia Parenteral Nutrition Revenue by Type (2021-2032)
  3. 11.1.2 Asia Parenteral Nutrition Sales by Type (2021-2032)
  4. 11.1.3 Asia Parenteral Nutrition Price by Type (2021-2032)
  5. 11.2 Asia Parenteral Nutrition Market Size by Application
  6. 11.2.1 Asia Parenteral Nutrition Revenue by Application (2021-2032)
  7. 11.2.2 Asia Parenteral Nutrition Sales by Application (2021-2032)
  8. 11.2.3 Asia Parenteral Nutrition Price by Application (2021-2032)
  9. 11.3 Asia Parenteral Nutrition Market Size by Country
  10. 11.3.1 Asia Parenteral Nutrition Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Parenteral Nutrition Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Parenteral Nutrition Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Parenteral Nutrition Market Size by Type
  2. 12.1.1 SAMEA Parenteral Nutrition Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Parenteral Nutrition Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Parenteral Nutrition Price by Type (2021-2032)
  5. 12.2 SAMEA Parenteral Nutrition Market Size by Application
  6. 12.2.1 SAMEA Parenteral Nutrition Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Parenteral Nutrition Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Parenteral Nutrition Price by Application (2021-2032)
  9. 12.3 SAMEA Parenteral Nutrition Market Size by Country
  10. 12.3.1 SAMEA Parenteral Nutrition Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Parenteral Nutrition Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Parenteral Nutrition Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Parenteral Nutrition Value Chain Analysis
  2. 13.1.1 Parenteral Nutrition Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Parenteral Nutrition Production Mode & Process
  6. 13.2 Parenteral Nutrition Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Parenteral Nutrition Distributors
  9. 13.2.3 Parenteral Nutrition Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst